Nuclear Medicine Equipment Market: How Is PSMA PET Imaging Transforming Prostate Cancer Staging and Treatment Planning?
The Nuclear Medicine Equipment Market in 2026 is experiencing one of its most clinically impactful developments in prostate-specific membrane antigen PET imaging, where the FDA approvals of gallium-68 PSMA-11 and fluorine-18 piflufolastat PSMA tracers have created a clinical standard for prostate cancer staging, biochemical recurrence evaluation, and metastatic disease characterization that...
0 Commentarios 0 Acciones 8 Views 0 Vista previa
Lifesone https://lifesone.com